Seizures and myoclonus in patients with Alzheimer's disease.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 3092131)

Published in Neurology on September 01, 1986

Authors

W A Hauser, M L Morris, L L Heston, V E Anderson

Associated clinical trials:

Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) (LAPSE) | NCT04004702

Articles citing this

Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell (2012) 3.16

Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol (2009) 3.12

BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol (2007) 2.18

Widespread changes in network activity allow non-invasive detection of mesial temporal lobe seizures. Brain (2016) 2.11

Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol (2013) 1.68

Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.39

Seizures in Alzheimer disease: who, when, and how common? Arch Neurol (2009) 1.34

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain (2011) 1.10

Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav (2008) 1.09

Seizures and epilepsy in Alzheimer's disease. CNS Neurosci Ther (2011) 1.05

Incidence of new-onset seizures in mild to moderate Alzheimer disease. Arch Neurol (2012) 0.95

Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice. J Neurosci (2015) 0.91

Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy. Epilepsia (2007) 0.90

Alzheimer's secretases regulate voltage-gated sodium channels. Neurosci Lett (2010) 0.89

Seizures in Alzheimer disease: clinical and epidemiological data. Epilepsy Curr (2012) 0.87

Seizures in an Alzheimer's disease patient as a complication of colonoscopy premedication with meperidine. Dig Dis Sci (2007) 0.87

Synaptic released zinc promotes tau hyperphosphorylation by inhibition of protein phosphatase 2A (PP2A). J Biol Chem (2012) 0.85

Soy-based diet exacerbates seizures in mouse models of neurological disease. J Alzheimers Dis (2013) 0.83

Management of new-onset epilepsy in the elderly. Nat Rev Neurol (2009) 0.83

Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease. Ann Neurol (2016) 0.82

Epilepsy in India I: Epidemiology and public health. Ann Indian Acad Neurol (2015) 0.82

Hippocampal oscillatory activity in Alzheimer's disease: toward the identification of early biomarkers? Aging Dis (2013) 0.81

Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease. Neural Plast (2015) 0.81

Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation. Sci Rep (2014) 0.80

Hyperpolarization-activated cyclic nucleotide gated channels: a potential molecular link between epileptic seizures and Aβ generation in Alzheimer's disease. Mol Neurodegener (2012) 0.79

How important is Alzheimer's disease as a risk factor for unprovoked seizures and epilepsy in the elderly? Epilepsy Curr (2010) 0.77

Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's Disease. Neural Plast (2016) 0.77

The E280A presenilin mutation reduces voltage-gated sodium channel levels in neuronal cells. Neurodegener Dis (2013) 0.76

Seizures in corticobasal degeneration: a case report. Neurocase (2009) 0.75

The causes of new-onset epilepsy and seizures in the elderly. Neuropsychiatr Dis Treat (2016) 0.75

From Molecular Circuit Dysfunction to Disease: Case Studies in Epilepsy, Traumatic Brain Injury, and Alzheimer's Disease. Neuroscientist (2015) 0.75

Mechanisms of tau and Aβ-induced excitotoxicity. Brain Res (2015) 0.75

Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol (2016) 0.75

Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer's disease. Neurobiol Aging (2016) 0.75

Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia. J Alzheimers Dis (2017) 0.75

Synaptic adhesion molecule Pcdh-γC5 mediates synaptic dysfunction in Alzheimer's disease. J Neurosci (2017) 0.75

Articles by these authors

Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet (1998) 4.89

Remission of seizures and relapse in patients with epilepsy. Epilepsia (1979) 4.17

Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke (2001) 4.07

The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia (1975) 3.67

Microbiology of municipal solid waste composting. Adv Appl Microbiol (1975) 3.53

Comparative safety of antiepileptic drugs during pregnancy. Neurology (2012) 3.32

Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med (1987) 3.21

A population-based study of seizures after traumatic brain injuries. N Engl J Med (1998) 3.12

The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96

Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control (2000) 2.85

Risk of recurrent seizures after two unprovoked seizures. N Engl J Med (1998) 2.74

Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet (1995) 2.72

Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70

A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology (1996) 2.69

The protective effect of moderate alcohol consumption on ischemic stroke. JAMA (1999) 2.68

Long-term mortality after a first episode of status epilepticus. Neurology (2002) 2.60

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology (2009) 2.58

Oxidative damage in Alzheimer's. Nature (1996) 2.55

Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med (1995) 2.33

The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology (2005) 2.32

The syndrome of pits of the lower lip and cleft lip and/or palate. Genetic considerations. Am J Hum Genet (1967) 2.32

Seizure recurrence after a first unprovoked seizure. N Engl J Med (1982) 2.23

Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2008) 2.22

Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst (1997) 2.21

Cysticercosis and epilepsy: a critical review. Epilepsia (1998) 2.21

Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology (2001) 2.19

Hypertension and the risk of new-onset unprovoked seizures. Neurology (1993) 2.19

Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. JAMA (1991) 2.18

Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology (2011) 2.06

Major depression is a risk factor for seizures in older adults. Ann Neurol (2000) 2.05

How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world. Mov Disord (1998) 2.03

Psychiatric disorders in foster home reared children of schizophrenic mothers. Br J Psychiatry (1966) 2.03

Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke (1997) 2.00

A prospective study of recurrent febrile seizures. N Engl J Med (1992) 1.99

Heterogeneity in the inheritance of alcoholism. A study of male and female twins. Arch Gen Psychiatry (1991) 1.99

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J Clin Immunol (2004) 1.98

Novel association approach for determining the genetic predisposition to schizophrenia: case-control resource and testing of a candidate gene. Am J Med Genet (1993) 1.95

Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility. Genomics (1992) 1.95

Semistructured interview for seizure classification: agreement with physicians' diagnoses. Epilepsia (1990) 1.93

Linkage analysis between the major histocompatibility system and insulin-dependent diabetes in families with patients in two consecutive generations. J Clin Invest (1980) 1.90

Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am J Hum Genet (1988) 1.84

Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett (1992) 1.82

Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology (1990) 1.76

Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology (1998) 1.72

Reliability of seizure classification using a semistructured interview. Neurology (1993) 1.71

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Vaccine (2004) 1.71

Driving and epilepsy. A review and reappraisal. JAMA (1991) 1.69

Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions. Arch Gen Psychiatry (1981) 1.67

LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology (2004) 1.67

Predictors of disease course in patients with probable Alzheimer's disease. Neurology (1987) 1.66

The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics (1996) 1.65

Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol (1994) 1.63

The risk of epilepsy following febrile convulsions. Neurology (1979) 1.61

Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology (1992) 1.61

Classification of partial seizure symptoms in genetic studies of the epilepsies. Neurology (2006) 1.59

Mortality in patients with epilepsy. Epilepsia (1980) 1.56

Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol (2000) 1.56

Epidemiology of epilepsy. Adv Neurol (1978) 1.54

Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet (1996) 1.54

Population-based study of seizure disorders after cerebral infarction. Neurology (1996) 1.52

Short-term mortality after a first episode of status epilepticus. Epilepsia (1997) 1.49

Relations of genetic and environmental factors in the etiology of epilepsy. Ann Neurol (1996) 1.47

Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol (1998) 1.46

Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology (2000) 1.44

Pycnodysostosis. Clinical and genetic considerations. Am J Dis Child (1968) 1.43

Incidence and prognosis of Bell's palsy in the population of Rochester, Minnesota. Mayo Clin Proc (1971) 1.42

Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature (1989) 1.40

Risk factors for a first febrile seizure: a matched case-control study. Epilepsia (1995) 1.40

Tourette's disorder in a set of reared-apart triplets: genetic and environmental influences. Am J Psychiatry (1990) 1.39

Analysis of linkage between the major histocompatibility system and juvenile, insulin-dependent diabetes in multiplex families. Reanalysis of data. J Clin Invest (1978) 1.38

Hypohidrotic ectodermal dysplasia in females. A critical analysis and argument for genetic heterogeneity. Z Kinderheilkd (1970) 1.38

Dementia and adult-onset unprovoked seizures. Neurology (1996) 1.37

Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia (1995) 1.37

Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation. Neurology (1997) 1.35

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology (2009) 1.33

The relational-interdependent self-construal and relationships. J Pers Soc Psychol (2000) 1.32

Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology (2001) 1.31

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology (2009) 1.31

Risk of recurrence after an initial unprovoked seizure. Epilepsia (1986) 1.31

Apolipoprotein E genotype and Alzheimer's disease. Lancet (1993) 1.30

Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan Stroke Study. Neuroepidemiology (1999) 1.29

Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc (1996) 1.28

Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia (1998) 1.28

Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J Histochem Cytochem (1998) 1.27

Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest. Hum Mol Genet (1998) 1.26

Congenital localized absence of skin and associated abnormalities resembling epidermolysis bullosa. A new syndrome. Arch Dermatol (1966) 1.26

Assay of low deuterium enrichment of water by isotopic exchange with [U-13C3]acetone and gas chromatography-mass spectrometry. Anal Biochem (1998) 1.24

Alzheimer's disease, trisomy 21, and myeloproliferative disorders: associations suggesting a genetic diathesis. Science (1977) 1.24

Short arm deletion of chromosome 18 in cebocephaly. Am J Dis Child (1968) 1.23

Clinical indicators of genetic susceptibility to epilepsy. Epilepsia (1996) 1.23

Spinocerebellar ataxia in a large kindred: age at onset, reproduction, and genetic linkage studies. Neurology (1984) 1.22

Predictors of recurrent febrile seizures: a metaanalytic review. J Pediatr (1990) 1.21

Psychologic and social adjustment to epilepsy in Rochester, Minnesota. Neurology (1989) 1.20

Severe, uncontrolled hypertension and adult-onset seizures: a case-control study in Rochester, Minnesota. Epilepsia (1996) 1.20

Are generalized and localization-related epilepsies genetically distinct? Arch Neurol (1998) 1.20

Epidemiology and the genetics of epilepsy. Res Publ Assoc Res Nerv Ment Dis (1983) 1.19

Frequency and clinical determinants of dementia after ischemic stroke. Neurology (2000) 1.19